7Baggers
 non muscle invasive bladder cancer pipeline 2025: pioneering  openPR.com Tue, 30 Sep 2025 17:42:04 GMT
 tyra biosciences, inc. $tyra shares sold by canaan partners xi llc  MarketBeat Tue, 30 Sep 2025 09:53:15 GMT
 Tyra stock plunges 17% amid TYRA-300 study data release  MSN Thu, 25 Sep 2025 16:32:37 GMT
 published on: 2025-09-19 06:13:20  khodrobank.com Fri, 19 Sep 2025 02:45:56 GMT
 published on: 2025-09-18 20:08:13  خودرو بانک Thu, 18 Sep 2025 16:38:47 GMT
 Tyra Biosciences (NASDAQ:TYRA) Upgraded at Wall Street Zen  MarketBeat Thu, 18 Sep 2025 07:00:00 GMT
 published on: 2025-09-18 20:08:13  خودرو بانک Wed, 17 Sep 2025 19:10:58 GMT
 published on: 2025-09-15 05:42:29  newser.com Mon, 15 Sep 2025 10:42:29 GMT
 published on: 2025-09-14 15:10:59  newser.com Sun, 14 Sep 2025 20:10:59 GMT
 published on: 2025-09-13 14:40:29  newser.com Sat, 13 Sep 2025 19:40:29 GMT
 tyra biosciences, inc. (tyra): investor outlook reveals 152.61% potential upside  DirectorsTalk Interviews Fri, 12 Sep 2025 09:29:49 GMT
 nuveen llc takes $465,000 position in tyra biosciences, inc. $tyra  MarketBeat Thu, 11 Sep 2025 07:27:33 GMT
 49,998 shares in tyra biosciences, inc. $tyra bought by nuveen llc  MarketBeat Wed, 10 Sep 2025 09:51:56 GMT
 nuveen llc takes $465,000 position in tyra biosciences, inc. $tyra  MarketBeat Wed, 10 Sep 2025 07:00:00 GMT
 published on: 2025-09-08 16:08:04  beatles.ru Mon, 08 Sep 2025 13:09:17 GMT
 published on: 2025-09-08 02:38:14  Newser Mon, 08 Sep 2025 07:38:14 GMT
 inside pharma’s race to deliver new treatments for dwarfism  PharmaVoice Mon, 08 Sep 2025 07:00:00 GMT
 nuveen llc invests $465,000 in tyra biosciences, inc. $tyra  MarketBeat Mon, 08 Sep 2025 07:00:00 GMT
 nuveen llc acquires new stake in tyra biosciences, inc. $tyra  Defense World Fri, 05 Sep 2025 07:38:07 GMT
 published on: 2025-09-03 23:02:23  Newser Thu, 04 Sep 2025 04:02:23 GMT
 tyra biosciences, inc. $tyra position boosted by alphaquest llc  MarketBeat Wed, 03 Sep 2025 07:00:00 GMT

Tyra Biosciences, Inc.
(NASDAQ:TYRA) 

TYRA stock logo

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatm...

Founded: 2018
CEO / Co-Founder: Todd Harris 
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends